Supreme Court Gives Vape Firms More Power to Sue FDA

Can vape companies really take the FDA to court outside of Washington, D.C.?

According to a recent Supreme Court decision—yes, they can. In a 7–2 ruling, the justices opened the door for vape manufacturers to file lawsuits against the Food and Drug Administration (FDA) in federal courts across the country, not just in the District of Columbia.

This is a major legal shift. Until now, the FDA had successfully argued that challenges to its product decisions—such as denying a company’s request to sell flavored vapes—had to be heard only in the D.C. Circuit. That meant many vape companies, especially smaller ones, faced expensive and complicated legal hurdles just to challenge federal actions.

Now, the game has changed. The Supreme Court’s ruling gives vape companies the ability to fight back locally, in courts closer to where they operate. And that could have serious consequences for how vaping products are regulated moving forward.

This article breaks down what the ruling means, why it matters, and how it could reshape the future of both the vaping industry and FDA oversight. Whether you’re a business owner, a consumer, or just someone tracking legal developments, here’s what you need to know.

The Supreme Court’s Decision

On June 20, 2025, the Supreme Court issued a 7–2 decision that fundamentally alters the legal battleground between vape companies and the Food and Drug Administration. The case centered around whether challenges to the FDA’s product rulings must be filed exclusively in the U.S. Court of Appeals for the D.C. Circuit.

The majority opinion, authored by Justice Neil Gorsuch, ruled that vape manufacturers can bring their lawsuits in other federal courts as well. This means a company in Texas, for example, could now file suit in the Fifth Circuit rather than travel to Washington, D.C.

Why This Ruling Matters

This may seem like a procedural technicality—but it carries big implications. Before the ruling, vape companies had only one venue to challenge the FDA: the D.C. Circuit, which often sided with the agency. That centralized process created what many in the vaping industry saw as an unfair advantage for the FDA.

With this decision, those companies now have a wider field of play. Different circuits can yield different outcomes, giving vape firms better odds of success or at least more leverage in legal battles. It essentially decentralizes oversight of FDA enforcement—something the government strongly opposed.

The Industry’s Response

Many vape companies welcomed the ruling, calling it a step toward fairness. Small and mid-sized businesses have long argued that the FDA’s application process for tobacco product approvals is both costly and opaque. They say that being able to challenge denials in their home jurisdictions will help level the playing field.

Some public health advocates, however, have warned that the decision could lead to a patchwork of rulings that weaken national standards for vape regulation. This could make it harder to enforce consistent rules across all states, particularly when it comes to flavored products that appeal to younger users.

The FDA’s Authority Under Pressure

This isn’t the first time the FDA’s tobacco regulations have faced legal challenges. Since 2016, when the agency extended its authority to cover e-cigarettes and vape products, there’s been a wave of lawsuits from manufacturers denied approval.

The Supreme Court’s ruling doesn’t eliminate the FDA’s power, but it adds a new layer of legal complexity. Now, federal judges in circuits across the country will have a say in how vaping regulations are interpreted and enforced.

That could open the door to forum shopping—where companies pick courts that are more likely to rule in their favor. It could also pressure the FDA to rethink how it evaluates and communicates its decisions to avoid contradictory rulings.

What Comes Next?

For the vaping industry, this ruling signals a more favorable environment for pushing back against federal restrictions. Already, several companies have announced plans to file suits in other circuits, hoping for outcomes different from those in the D.C. court.

For consumers, especially those concerned about youth vaping, this legal shift could slow down or weaken regulatory enforcement. The public health debate over e-cigarettes is far from over, and now it will play out in courtrooms from coast to coast.

The future of vape regulation just became a lot more uncertain. What remains to be seen is how the FDA will respond—and whether Congress will step in to clarify the rules.

Understanding the Court’s Ruling on Vape Lawsuits

What exactly did the Supreme Court decide?

The Supreme Court ruled that vape companies can sue the FDA in federal courts across the country—not just in Washington, D.C. This means that if the FDA denies a company’s application to sell a vape product, that company can now challenge the decision in a court near their base of operations.

Previously, the FDA argued that such lawsuits could only be filed in the D.C. Circuit, which is known for often siding with federal agencies. This decision changes that rule, giving businesses more legal flexibility.

Why is this ruling important for vape companies?

Before this decision, many vape companies—especially small ones—felt locked out of the legal process. Suing in Washington, D.C. was expensive and complex. Now, they can fight back locally, reducing costs and possibly getting more favorable rulings from judges outside of the D.C. Circuit.

This shift increases their odds of success in regulatory challenges and could influence how the FDA handles future product reviews.

Does this ruling weaken the FDA’s authority?

Not directly. The FDA still has the power to regulate tobacco and vape products under federal law. What’s changed is where companies can challenge the agency’s decisions.

But it does create new complications for the FDA. With more courts involved, there’s a higher risk of inconsistent rulings. This may force the agency to defend its decisions in multiple regions, which could slow down enforcement and policymaking.

Could this lead to different vape laws in different states?

Not exactly. Federal laws remain consistent across states. However, federal circuit courts can interpret regulations differently, and that could create a temporary patchwork effect.

For example, if one court rules in favor of a vape company while another rules against a similar claim, it sends mixed signals to regulators and businesses. Until the Supreme Court settles those conflicts, rules could vary in practice.

What does this mean for consumers and public health?

Public health groups worry that this ruling may delay or weaken efforts to restrict youth-targeted vape products. If the FDA loses challenges in certain courts, companies might be able to keep selling products that otherwise would have been banned.

At the same time, vape companies argue that the ruling simply ensures they get a fair chance to defend their products and hold the FDA accountable. The decision opens the door for more transparency and balance in vape regulation.

Disclaimer: This section is for informational purposes only and does not constitute legal advice or create an attorney-client relationship. If you’re involved in vape regulation or a related business dispute, consider consulting with a qualified attorney in your jurisdiction.

Vaping, Courts, and the Balance of Power

Legal Access and Business Fairness

For vape companies, the Supreme Court’s decision is more than a procedural change—it’s a victory in their long-standing battle with the FDA. Being able to file lawsuits outside of Washington, D.C., levels the playing field, especially for smaller companies that can’t afford the high costs of centralized litigation.

This decision reaffirms a core principle of justice: access to the legal system should not depend on location or wealth. By expanding where these lawsuits can be filed, the Court has given businesses a real chance to stand up for themselves and challenge powerful federal agencies.

Still, access to the courts doesn’t guarantee a win. But it opens doors. And that matters when regulation can mean the life or death of a small business.

The Future of FDA Oversight

This ruling will have ripple effects. The FDA may now need to rethink how it makes and explains its decisions. It could also face more challenges, more legal opinions, and potentially more defeats in regions less sympathetic to federal authority.

That doesn’t mean regulation will disappear. But it does mean that the legal system is now a more active part of the regulatory landscape. Courts in different states may start shaping what’s acceptable in the vaping market—sometimes before the FDA can react.

This puts pressure on Congress too. Without clear federal legislation on vaping, regulatory battles will continue to play out in fragmented, costly ways that confuse businesses and leave consumers in limbo.

A Public Health Dilemma

While vape companies celebrate a legal victory, public health advocates are bracing for setbacks. If more courts block FDA decisions, products that were meant to be removed from the market could remain available—especially flavored ones that appeal to teens.

That tension between business rights and public health won’t go away. It’s at the heart of the vaping debate. And this case highlights just how hard it is to find the right balance.

Who gets to decide what’s safe, and who has the right to challenge that decision? Those questions now rest not only with the FDA—but with judges across the nation.

At the end of the day, this ruling reminds us that law and policy are living systems. As technology evolves and markets shift, the courts remain a critical part of shaping how power is distributed and how rights are protected.

Knowing your rights—and where you can defend them—is more important than ever. Whether you agree with the vaping industry or not, this case shows just how vital access to justice is in a democracy.